DONNINI SANDRA | Professor page

Ciccone, V., Cecchin, C., Frosini, M., Saletti, M., Maramai, S., Giuliani, G., et al. (2026). VA1213, a selective COX-2 inhibitor, exhibits antitumor activity by suppressing EGFR, AKT, and ERK1/2 phosphorylation. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES [10.1016/j.ejps.2025.107422]. - view more
Cursaro, I., Ciccone, V., Tudino, V., Papulino, C., Scalvini, L., Donnini, S., et al. (2025). Reversing TGF-β1-induced fibrotic phenotype in human lung fibroblasts using a PROTAC tool derived from an indoline-based HDAC6 inhibitor. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS, 14 [10.1016/j.ejmcr.2025.100276]. - view more
Ciccone, V., Simonis, V., Del Gaudio, C., Cucini, C., Ziche, M., Morbidelli, L., et al. (2024). ALDH1A1 confers resistance to RAF/MEK inhibitors in melanoma cells by maintaining stemness phenotype and activating PI3K/AKT signaling. BIOCHEMICAL PHARMACOLOGY, 224 [10.1016/j.bcp.2024.116252]. - view more
Filippelli, A., Ciccone, V., Del Gaudio, C., Simonis, V., Frosini, M., Tusa, I., et al. (2024). ERK5 mediates pro-tumorigenic phenotype in non-small lung cancer cells induced by PGE2. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1871(7) [10.1016/j.bbamcr.2024.119810]. - view more
Silvestri, C., Stasi, C., Profili, F., Bartolacci, S., Sessa, E., Tacconi, D., et al. (2024). Retrospective Study on the Features and Outcomes of a Tuscany COVID-19 Hospitalized Patients Cohort: Preliminary Results. JOURNAL OF CLINICAL MEDICINE, 13(16) [10.3390/jcm13164626]. - view more

All publications